#4438 on the rich list of 14,644 insiders
Thomas Trimarchi
President and CFO at BridgeBio Pharma. Based in Palo Alto, California.
$24.5M
in disclosed stock, +$53K (+0.22%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
- Rank
- 4438th of 14,644
- Companies held
- 1
- Largest holding
- BBIO, 100.0% of total
- Latest SEC filing
- Nov 16, 2026
What the $24.5M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| BridgeBio Pharma BBIO Common Stock | Directly | 313,748 | $78.18 | $24.5M | 100.0% | Form 4, Nov 16, 2026 |
Share counts are the amounts Thomas Trimarchi reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 4435 | Vlieger Robert W. De II Director, Northpointe Bancshares. Grand Rapids, MI | $24.5M |
| 4436 | Christopher O. Blunt Director, F&G Annuities & Life. Des Moines, IA | $24.5M |
| 4437 | Steven A. Raymund Director, Jabil. St. Petersburg, FL | $24.5M |
| 4438 | Thomas Trimarchi President and CFO, BridgeBio Pharma. Palo Alto, CA | $24.5M |
| 4439 | Ankur Sinha Chief Product and Tech Officer, Remitly Global. Seattle, WA | $24.5M |
| 4440 | Anthony Saravanos Division President, HCI Group. Tampa, FL | $24.5M |
| 4441 | Erica Ellen Smith Chief Financial Officer, Klaviyo. Boston, MA | $24.5M |
Other BridgeBio Pharma insiders
All BBIO insiders- Neil Kumar$438MChief Executive Officer. #525 overall
- Charles J. Homcy$71.9MDirector. #1924 overall
- Frank McCormick$60.0MDirector. #2240 overall
- Ali J. Satvat$13.3MDirector. #7082 overall
- Maricel Apuli$9.1MChief Accounting Officer. #9440 overall
- Brian C. Stephenson$8.0MCFO and Treasurer. #9997 overall
Questions
How much stock does Thomas Trimarchi own?
Thomas Trimarchi holds $24,528,819 in listed stock based on SEC filings and current prices, mostly BridgeBio Pharma (BBIO). That ranks 4438th on the Stock Rich List.
Is this Thomas Trimarchi's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Thomas Trimarchi last buy or sell stock?
The most recent open-market trade on file is a sale of 10,456 BBIO shares on May 18, 2026 at $64.82.